The increased reliability and efficiency of the quantitative polymerase chain reaction (qPCR) makes it a promising tool for performing large-scale screening for infectious disease among high-risk individuals. To date, no study has evaluated the specificity and sensitivity of different qPCR assays for leprosy diagnosis using a range of clinical samples that could bias molecular results such as difficult-to-diagnose cases. In this study, qPCR assays amplifying different M. leprae gene targets, sodA, 16S rRNA, RLEP and Ag 85B were compared for leprosy differential diagnosis. qPCR assays were performed on frozen skin biopsy samples from a total of 62 patients: 21 untreated multibacillary (MB), 26 untreated paucibacillary (PB) leprosy patients, as well as 10 patients suffering from other dermatological diseases and 5 healthy donors. To develop standardized protocols and to overcome the bias resulted from using chromosome count cutoffs arbitrarily defined for different assays, decision tree classifiers were used to estimate optimum cutoffs and to evaluate the assays. As a result, we found a decreasing sensitivity for Ag 85B (66.1%), 16S rRNA (62.9%), and sodA (59.7%) optimized assay classifiers, but with similar maximum specificity for leprosy diagnosis. Conversely, the RLEP assay showed to be the most sensitive (87.1%). Moreover, RLEP assay was positive for 3 samples of patients originally not diagnosed as having leprosy, but these patients developed leprosy 5–10 years after the collection of the biopsy. In addition, 4 other samples of patients clinically classified as non-leprosy presented detectable chromosome counts in their samples by the RLEP assay suggesting that those patients either had leprosy that was misdiagnosed or a subclinical state of leprosy. Overall, these results are encouraging and suggest that RLEP assay could be useful as a sensitive diagnostic test to detect M. leprae infection before major clinical manifestations.
References
[1]
Ridley DS, Jopling WH (1966) Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34: 255–273.
[2]
Ridley DS, Jopling WH (1962) A classification of leprosy for research purposes. Lepr Rev 33: 119–128.
[3]
Jardim MR, Antunes SL, Santos AR, Nascimento OJ, Nery JA, et al. (2003) Criteria for diagnosis of pure neural leprosy. J Neurol 250: 806–809. doi: 10.1007/s00415-003-1081-5
[4]
Shepard CC (1960) The Experimental Disease That Follows the Injection of Human Leprosy Bacilli into Foot-Pads of Mice. J Exp Med 112: 445–454. doi: 10.1084/jem.112.3.445
[5]
Kirchheimer WF, Storrs EE (1971) Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo. Int J Lepr Other Mycobact Dis 39: 693–702.
[6]
Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, et al. (2001) Massive gene decay in the leprosy bacillus. Nature 409: 1007–1011. doi: 10.1038/35059006
[7]
Kampirapap K, Singtham N, Klatser PR, Wiriyawipart S (1998) DNA amplification for detection of leprosy and assessment of efficacy of leprosy chemotherapy. Int J Lepr Other Mycobact Dis 66: 16–21.
[8]
Scollard DM, Gillis TP, Williams DL (1998) Polymerase chain reaction assay for the detection and identification of Mycobacterium leprae in patients in the United States. Am J Clin Pathol 109: 642–646.
[9]
Plikaytis BB, Gelber RH, Shinnick TM (1990) Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay. J Clin Microbiol 28: 1913–1917.
[10]
Martinez AN, Britto CF, Nery JA, Sampaio EP, Jardim MR, et al. (2006) Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy. J Clin Microbiol 44: 3154–3159. doi: 10.1128/JCM.02250-05
[11]
Rudeeaneksin J, Srisungngam S, Sawanpanyalert P, Sittiwakin T, Likanonsakul S, et al. (2008) LightCycler real-time PCR for rapid detection and quantitation of Mycobacterium leprae in skin specimens. FEMS Immunol Med Microbiol 54: 263–270. doi: 10.1111/j.1574-695X.2008.00472.x
[12]
Martinez AN, Lahiri R, Pittman TL, Scollard D, Truman R, et al. (2009) Molecular determination of Mycobacterium leprae viability by use of real-time PCR. J Clin Microbiol 47: 2124–2130. doi: 10.1128/JCM.00512-09
[13]
Truman RW, Andrews PK, Robbins NY, Adams LB, Krahenbuhl JL, et al. (2008) Enumeration of Mycobacterium leprae using real-time PCR. PLoS Negl Trop Dis 2: e328. doi: 10.1371/journal.pntd.0000328
[14]
Katoch VM, Lavania M, Chauhan DS, Sharma R, Hirawati , et al. (2007) Recent advances in molecular biology of leprosy. Indian J Lepr 79: 151–166.
[15]
Kang TJ, Kim SK, Lee SB, Chae GT, Kim JP (2003) Comparison of two different PCR amplification products (the 18-kDa protein gene vs. RLEP repetitive sequence) in the diagnosis of Mycobacterium leprae. Clin Exp Dermatol 28: 420–424. doi: 10.1046/j.1365-2230.2003.01300.x
[16]
Quinlan JR (1993) C4.5 Programs for machine learning. San Mateo: Morgan Kaufmann Publishers.
[17]
Ridley DS, Hilson GR (1967) A logarithmic index of bacilli in biopsies. I. Method. Int J Lepr Other Mycobact Dis 35: 184–186.
[18]
Phetsuksiri B, Rudeeaneksin J, Supapkul P, Wachapong S, Mahotarn K, et al. (2006) A simplified reverse transcriptase PCR for rapid detection of Mycobacterium leprae in skin specimens. FEMS Immunol Med Microbiol 48: 319–328. doi: 10.1111/j.1574-695X.2006.00152.x
[19]
Donoghue HD, Holton J, Spigelman M (2001) PCR primers that can detect low levels of Mycobacterium leprae DNA. J Med Microbiol 50: 177–182.
[20]
Goulart IM, Goulart LR (2008) Leprosy: diagnostic and control challenges for a worldwide disease. Arch Dermatol Res 300: 269–290. doi: 10.1007/s00403-008-0857-y
[21]
Cardoso CC, Pereira AC, de Sales Marques C, Moraes MO (2011) Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome. Future Microbiol 6: 533–549. doi: 10.2217/fmb.11.39
[22]
Kent L, McHugh TD, Billington O, Dale JW, Gillespie SH (1995) Demonstration of homology between IS6110 of Mycobacterium tuberculosis and DNAs of other Mycobacterium spp.? J Clin Microbiol 33: 2290–2293.
[23]
McHugh TD, Newport LE, Gillespie SH (1997) IS6110 homologs are present in multiple copies in mycobacteria other than tuberculosis-causing mycobacteria. J Clin Microbiol 35: 1769–1771.
[24]
Torres P, Camarena JJ, Gomez JR, Nogueira JM, Gimeno V, et al. (2003) Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts. Lepr Rev 74: 18–30.
[25]
Jardim MR, Antunes SL, Simons B, Wildenbeest JG, Nery JA, et al. (2005) Role of PGL-I antibody detection in the diagnosis of pure neural leprosy. Lepr Rev 76: 232–240.
[26]
Schuring RP, Moet FJ, Pahan D, Richardus JH, Oskam L (2006) Association between anti-pGL-I IgM and clinical and demographic parameters in leprosy. Lepr Rev 77: 343–355.
[27]
Wichitwechkarn J, Karnjan S, Shuntawuttisettee S, Sornprasit C, Kampirapap K, et al. (1995) Detection of Mycobacterium leprae infection by PCR. J Clin Microbiol 33: 45–49.
[28]
Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005–1015. doi: 10.1056/NEJMoa0907847
[29]
Banerjee S, Sarkar K, Gupta S, Mahapatra PS, Guha S, et al. (2010) Multiplex PCR technique could be an alternative approach for early detection of leprosy among close contacts–a pilot study from India. BMC Infect Dis 10: 252. doi: 10.1186/1471-2334-10-252
